Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP.
JACC Basic Transl Sci
; 4(8): 962-972, 2019 Dec.
Article
en En
| MEDLINE
| ID: mdl-31909303
ACC, American College of Cardiology; AHA, American Heart Association; ANP, atrial natriuretic peptide; B-type natriuretic peptide; BNP, B-type natriuretic peptide; GFR, glomerular filtration rate; HF, heart failure; LAVI, left atrial volume index; LVEDV, left ventricular end-diastolic volume; LVEF, left ventricular ejection fraction; LVESV, left ventricular end-systolic volume; NP, natriuretic peptide; PDEV, type V phosphodiesterase; PSD, preclinical systolic dysfunction; RPF, renal plasma flow; SC, subcutaneous; VE, acute saline volume expansion; cGMP, cyclic guanosine monophosphate; cardiorenal; heart failure; nesiritide; phosphodiesterase inhibition; systolic dysfunction
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Clinical_trials
Idioma:
En
Revista:
JACC Basic Transl Sci
Año:
2019
Tipo del documento:
Article
Pais de publicación:
Estados Unidos